GC Cell Corporation (KOSDAQ:144510)
23,100
+250 (1.09%)
Apr 10, 2026, 3:30 PM KST
GC Cell Market Cap
GC Cell has a market cap or net worth of 347.13 billion as of April 10, 2026. Its market cap has increased by 1.76% in one year.
Market Cap
347.13B
Enterprise Value
429.88B
Revenue
165.52B
Ranking
n/a
PE Ratio
n/a
Stock Price
23,100.00
Market Cap Chart
Since June 23, 2016, GC Cell's market cap has decreased from 507.65B to 347.13B, a decrease of -31.62%. That is a compound annual growth rate of -3.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 347.13B | -7.04% |
| Dec 30, 2025 | 373.42B | 4.85% |
| Dec 30, 2024 | 356.14B | -47.90% |
| Dec 28, 2023 | 683.53B | -3.46% |
| Dec 29, 2022 | 708.04B | -55.94% |
| Dec 30, 2021 | 1.61T | 65.31% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Jun 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Green Cross Holdings | 619.73B |
| SillaJen | 530.42B |
| Helixmith | 433.76B |
| Genomictree | 417.38B |
| Anterogen.Co.,Ltd. | 401.24B |
| BINEX | 358.29B |
| JETEMA, | 284.65B |
| HLB Therapeutics | 271.52B |